Trilliome Trilliome
News Subscribe
Partner with us
Ingredients

Precision bioactives, built to formulate.

Two actives heading to market, and a pipeline behind them — all from one engine, all designed for real products.

Heading to market
TRI-04 · first to market

Low-MW prebiotic fibre

A water-soluble prebiotic fibre that supports the gut's short-chain fatty acid producers, with a metabolic-health claim path under study. Lean Self-Affirmed GRAS pathway; first revenue targeted Q2 2027.

Explore TRI-04 TRI-01

Precision gut-brain activator

A shelf-stable active that selectively induces a named four-species consortium of keystone gut bacteria — keystone species whose benefits reach beyond butyrate. Gut-health claims at launch; gut-brain as the evidence builds. Self-Affirmed GRAS pathway; first revenue targeted H2 2027 onward.

Explore TRI-01
In development
Teroka output

The pipeline

A pipeline of precision bioactives across nutraceutical and cosmeceutical applications — from discovery to development.

See the pipeline
Shared by design. Every active shares the same DNA: species- or network-level precision, milligram-to-low-gram dosing, shelf-stability, clean extraction from upcycled side-streams, and a substantiation pathway. They come from one engine — Teroka.
Partner with us The science
What ingredients does Trilliome offer?
Two market-bound actives — TRI-01 (gut-brain activator) and TRI-04 (low-MW prebiotic fibre) — plus a development pipeline.
What's the difference between TRI-01 and TRI-04?
TRI-01 induces specific named species directly at milligram doses; TRI-04 is a water-soluble prebiotic fibre that nourishes the broader community of butyrate-producing bacteria.
When do pipeline products reach market?
TRI-04 is first, with TRI-01 following. The rest of the pipeline spans discovery to development.